Literature DB >> 10527911

Role of Ca(2+) in the regulation of nickel-inducible Cap43 gene expression.

K Salnikow1, T Kluz, M Costa.   

Abstract

We have recently cloned a gene, Cap43, that was significantly induced by exposure to nontoxic levels of both water-soluble and -insoluble Ni(2+) compounds. In this paper, we utilized the expression levels of this gene as a tool to identify second messengers involved in nickel-inducible transcription. We report here that the Ca(2+) ionophore A23187 substantially stimulated Cap43 gene expression. In addition, we found that BAPTA-AM, a specific chelator of free intracellular Ca(2+), consistently attenuated the induction of Cap43, indicating that elevation of intracellular Ca(2+) was essential for this response. TPEN, a chelator of heavy metals, such as Ni(2+) with a very low affinity for Ca(2+), did not attenuate Cap43 induced by Ni or calcium ionophore, suggesting that elevations of Ca(2+) but probably not elevations of other metal ions were involved in the induction of Cap43. A direct measurement of Ca(2+) levels using the fluorescent probe Fluo-3 AM showed elevations of free intracellular Ca(2+) in Ni-treated cells. A strong induction of Cap43 by okadaic acid suggested the involvement of a serine/threonine phosphorylation in a signaling pathway that was presumably activated by Ni and that led to enhanced Cap43 gene expression. However, calcium-dependent protein kinase(s) involved in the nickel-activated signaling pathway remains to be identified. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527911     DOI: 10.1006/taap.1999.8759

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

1.  Alterations of histone modifications by cobalt compounds.

Authors:  Qin Li; Qingdong Ke; Max Costa
Journal:  Carcinogenesis       Date:  2009-04-17       Impact factor: 4.944

2.  Different mechanism of LPS-induced calcium increase in human lung epithelial cell and microvascular endothelial cell: a cell culture study in a model for ARDS.

Authors:  Kejing Zhang; Ping Wang; Shuaishuai Huang; Xue Wang; Taohong Li; Yuhong Jin; Michael Hehir; Chiyi Xu
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

3.  N-myc downstream-regulated gene 1 (NDRG1) a differentiation marker of human breast cancer.

Authors:  Abbas Fotovati; Samah Abu-Ali; Masayoshi Kage; Kazuo Shirouzu; Hideaki Yamana; Michihiko Kuwano
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

4.  The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia.

Authors:  Konstantin Salnikow; Thomas Kluz; Max Costa; David Piquemal; Zoya N Demidenko; Keping Xie; Mikhail V Blagosklonny
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Cellular distribution of NDRG1 protein in the rat kidney and brain during normal postnatal development.

Authors:  Yoshinobu Wakisaka; Akiko Furuta; Katsuaki Masuda; Wataru Morikawa; Michihiko Kuwano; Toru Iwaki
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

6.  Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells.

Authors:  Hakan Cangul; Konstantin Salnikow; Herman Yee; David Zagzag; Therese Commes; Max Costa
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

7.  Involvement of the glycoproteic Ib-V-IX complex in nickel-induced platelet activation.

Authors:  S Riondino; F M Pulcinelli; P Pignatelli; P P Gazzaniga
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

8.  The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.

Authors:  Sushant K Kachhap; Dennis Faith; David Z Qian; Shabana Shabbeer; Nathan L Galloway; Roberto Pili; Samuel R Denmeade; Angelo M DeMarzo; Michael A Carducci
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.